Patents by Inventor Fanny Sylvie Michele Monneaux

Fanny Sylvie Michele Monneaux has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • PHOSPHORYLATED DERIVATIVES OF A U1-70K PEPTIDE AND THEIR USE IN THE TREATMENT OF AUTOIMMUNE PATHOLOGIES
    Publication number: 20140004136
    Abstract: Derivatives of the peptide corresponding to the sequence RIHMVYSKRSGKPRGYAFIEY (SEQ ID NO: 1), pharmaceutical compositions, and methods of use thereof are provided.
    Type: Application
    Filed: June 11, 2013
    Publication date: January 2, 2014
    Applicant: Centre National De La Recherche Scientifique
    Inventors: Sylviane Muller, Fanny Sylvie-Michele Monneaux, Jean-Paul Briand, Gilles Guichard, Jean-Gerard Guillet
  • Phosphorylated derivatives of a U1-70K peptide and their use in the treatment of autoimmune pathologies
    Patent number: 8475800
    Abstract: Derivatives of the peptide corresponding to the sequence RIHMVYSKRSGKPRGYAFIEY (SEQ ID NO: 1), pharmaceutical compositions, and methods of use thereof are provided.
    Type: Grant
    Filed: October 27, 2010
    Date of Patent: July 2, 2013
    Assignee: Centre National de la Recherche Scientifique
    Inventors: Sylviane Muller, Fanny Sylvie Michele Monneaux, Jean-Paul Briand, Gilles Guichard, Jean-Gerard Guillet
  • USE OF PEPTIDES COMPRISING POST-TRANSLATIONAL MODIFICATIONS IN THE TREATMENT OF AUTOIMMUNE PATHOLOGIES
    Publication number: 20120149652
    Abstract: Peptides including post-translational-type modifications, such as phosphorylation or acetylation of one or more amino acids, are provided. Processes for obtaining the peptides, pharmaceutical compositions including the peptides and methods for treating autoimmune diseases using the peptides are also provided.
    Type: Application
    Filed: October 27, 2010
    Publication date: June 14, 2012
    Applicant: CENTRE NATIONAL DE LA RECHERCHE SCIENTIFIQUE
    Inventors: Sylviane MULLER, Fanny Sylvie Michéle Monneaux, Jean-Paul Briand, Gilles Guichard, Jean-Gérard Guillet
  • Use of adenine-derived compounds for the treatment of lupus
    Patent number: 8058281
    Abstract: The present invention is directed to a method of treating systemic lupus erythematosus comprising administering a compound of formula (I) wherein R1 is selected from the group consisting of CF3, a C1-C5 alkyl, and (CH2)nR4, wherein n is between 0 and 4; R2 is selected from the group consisting of (CH2)mR4 and (CH2)mAr, wherein m is between 0 and 5; R3 is selected from the group consisting of hydrogen and methyl; R4 is selected from the group consisting of phenyl, OH, a C1-C3 alkoxy, a C1-C3 dialkylamino, piperidino, and N-methylpiperazino; Ar represents ?wherein X is selected from the group consisting of F, C1, a C1-C3 alkoxy, and CF3. The compounds can be used in combination with a second compound used in the treatment of systemic lupus erythematosus.
    Type: Grant
    Filed: March 6, 2007
    Date of Patent: November 15, 2011
    Assignee: Centre National de la Recherche Scientifique (CNRS)
    Inventors: Claire Renée Jeanne Lugnier, Sylviane Paule Ghislaine Muller, Fanny Sylvie Michèle Monneaux, Jean-Jaques Bourguignon
  • Phosphorylated derivatives of a U1-70K peptide and their use in the treatment of autoimmune pathologies
    Patent number: 7872098
    Abstract: Derivatives of the peptide corresponding to the sequence RIHMVYSKRSGKPRGYAFIEY (SEQ ID NO: 1), pharmaceutical compositions, and methods of use thereof are provided.
    Type: Grant
    Filed: September 18, 2002
    Date of Patent: January 18, 2011
    Assignee: Centre National de la Recherche Scientifique
    Inventors: Sylviane Muller, Fanny Sylvie Michele Monneaux, Jean-Paul Briand, Gilles Guichard, Jean-Gerard Guillet